0001493152-22-024345.txt : 20220830 0001493152-22-024345.hdr.sgml : 20220830 20220830080023 ACCESSION NUMBER: 0001493152-22-024345 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220830 DATE AS OF CHANGE: 20220830 EFFECTIVENESS DATE: 20220830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457338 FILM NUMBER: 221212911 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 D 1 primary_doc.xml X0708 D LIVE 0001321834 MyMD Pharmaceuticals, Inc. 855 N. WOLFE STREET SUITE 601 BALTIMORE MD MARYLAND 21205 (856) 848-8698 NEW JERSEY None Akers Biosciences, Inc. Akers Biosciences Inc Corporation true Chris Chapman 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Executive Officer Director Director, President and Chief Medical Officer Adam Kaplin 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Executive Officer Chief Scientific Officer Paul Rivard 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Executive Officer Executive Vice President of Operations and General Counsel Ian Rhodes 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Executive Officer Interim Chief Financial Officer Craig Eagle 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Director Christopher Schreiber 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Director Joshua Silverman 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Director Chairman of the Board Jude Uzonwanne 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Director Bill White 855 N. Wolfe Street Suite 601 Baltimore MD MARYLAND 21205 Director Other Health Care Decline to Disclose 06b false 2022-08-15 false true true false 0 Dawson James Securities, Inc. 130645 None None 101 NORTH FEDERAL HIGHWAY SUITE 600 BOCA RATON FL FLORIDA 33432 CT CONNECTICUT FL FLORIDA IL ILLINOIS NY NEW YORK false 7411761 0 7411761 Represents warrants to purchase up to 1,411,764 shares of common stock at $5.25/share. false 8 239999 0 0 false MyMD Pharmaceuticals, Inc. /s/ Chris Chapman Chris Chapman President, Chief Medical Officer, and Director 2022-08-30